Biolegend, 124312, APC anti-mouse CD274 (B7-H1, PD-L1) Antibody, 100μg

CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1 with PD-1 plays an important role in the inhibition of T cell responses. Other studies have shown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 is involved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, in an IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cell proliferation and cytokine production.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: Additional reported applications (for the relevant formats) include: immunofluorescence4, blocking6,7,8,9, and immunohistochemistry of acetone-fixed frozen sections4, 11. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 124303). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 124318) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Application References(PubMed link indicates BioLegend citation): Maier H, et al. 2007. J. Immunol. 178:2714. Meng Q, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:4444. PubMed Scarlett UK, et al. 2012. J Exp Med. 209:495. PubMed Grabie N, et al. 2007. Circulation 116:2062. (IF, IHC) Paterson AM, et al. 2011. J. Immunol. 187:1097. Channappanavar R, et al. 2012. PLoS One 7:e39757. (Block) Schreiber HA, et al. 2010. PLoS One 5:e11453. (Block) PubMed Muthumani K, et al. 2011. J. Immunol. 187:2932. (Block) PubMed Cripps JG, et al. 2010. Hepatology 52:1350. (Block) PubMed Murakami R, et al. 2013. PLoS One. 8:73270. PubMed Riella LV, et al. 2011. Am. J. Transplant 11:832-40. (IHC) Lei GS, et al. 2015. Infect Immun. 83:572. PubMed
Product Citations: Ngiow S, et al. 2016. Cancer Res . 76: 6266 - 6277. PubMed Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed Chen H, et al. 2023. Nat Commun. 14:941. PubMed Gu J, et al. 2023. J Cell Biochem. 124:557. PubMed Zhang X, et al. 2023. Heliyon. 9:e13490. PubMed Tsai KC, et al. 2023. Mar Drugs. 21:. PubMed Gu T, et al. 2023. Front Immunol. 14:1145028. PubMed Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed Song S, et al. 2023. Bioact Mater. 28:358. PubMed Schnell A, et al. 2021. Cell. 184:6281. PubMed Yang Z, et al. 2022. Cancer Discov. 12:1942. PubMed Wang X, et al. 2022. Sci Adv. 8:eabn0071. PubMed Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed An HW, et al. 2022. Cell Rep. 41:111878. PubMed Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed Yonemitsu K, et al. 2022. Sci Rep. 12:12007. PubMed Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed Pierini S, et al. 2021. J Immunother Cancer. 9:. PubMed Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed Lin R, et al. 2020. Sci Rep. 10:14397. PubMed Park S, et al. 2021. Front Immunol. 11:620166. PubMed Kiritsy MC, et al. 2021. Elife. 10:. PubMed Chen L, et al. 2020. Cancer Immunol Res. 0.457638889. PubMed Fu Y, et al. 2020. Sci Rep. 10:9027. PubMed Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed Zhang C, et al. 2022. J Extracell Vesicles. 11:e12209. PubMed Ren J, et al. 2021. Theranostics. 11:304. PubMed Findlay EG, et al. 2019. Oncoimmunology. 8:1608106. PubMed Bommireddy R, et al. 2020. Vaccines (Basel). 8:. PubMed Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed Pein M, et al. 2020. Nat Commun. 11:1494. PubMed Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed Zhou KX, et al. 2021. J Immunol Res. 2021:6694392. PubMed Tu J, et al. 2022. Theranostics. 12:747. PubMed Lovisa S, et al. 2020. Sci Signal. 13:00. PubMed Zhou L, et al. 2020. Clin Cancer Res. 26:290. PubMed Zhang P, et al. 2022. BMC Med. 20:435. PubMed Guo L, et al. 2021. Front Immunol. 12:785457. PubMed Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed Kennedy EM, et al. 2022. Nat Commun. 13:5907. PubMed Pradhan K, et al. 2021. Front Immunol. 12:778830. PubMed Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed Koikawa K, et al. 2021. Cell. 184:4753. PubMed Vardhana SA, et al. 2020. Nat Immunol. 1.584722222. PubMed Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed Almishri W, et al. 2015. J Hepatol. 63: 943-951. PubMed Fukumoto T, et al. 2019. Cancer Res. 79:5482. PubMed Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed Shen ZY, et al. 2021. Front Immunol. 12:589200. PubMed Barbet G, et al. 2018. Immunity. 48:584. PubMed Iwata TN, et al. 2018. Mol Cancer Ther. 17:1494. PubMed Franklin DA, et al. 2020. JCI Insight. 5:. PubMed Baldwin LA, et al. 2022. Nat Commun. 13:6539. PubMed Yi M, et al. 2022. J Hematol Oncol. 15:142. PubMed Li Q, et al. 2022. Front Oncol. 12:841977. PubMed Lindhorst A, et al. 2021. Cell Death Dis. 12:579. PubMed Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed Wang C, et al. 2018. Sci Transl Med. 10. PubMed Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed Shen H, et al. 2022. Nat Commun. 13:5013. PubMed Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed Liu YS, et al. 2021. Cancers (Basel). 13:. PubMed Luna-Yolba R, et al. 2021. Cancers (Basel). 13: . PubMed RL M, et al. 2015. Proc Natl Acad Sci U S A. 112:6506-6514. PubMed Lerbs T, et al. 2020. JCI Insight. 5:00. PubMed Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed Luo N, et al. 2018. Nat Commun. 0.547222222. PubMed Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
RRID: AB_10612935 (BioLegend Cat. No. 124311) AB_10612741 (BioLegend Cat. No. 124312)
Structure: 40 kD type I transmembrane protein member of B7 family within the immunoglobulin receptor superfamily
Distribution: T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes
Ligand/Receptor: PD-1 (PDCD1)
Cell Type: B cells, Dendritic cells, Endothelial cells, Monocytes, NK cells, T cells
Biology Area: Cancer Biomarkers, Costimulatory Molecules, Immunology
Molecular Family: Adhesion Molecules, CD Molecules, Immune Checkpoint Receptors
Antigen References: 1. Sharpe A, et al. 2007. Nat. Immunol. 8:239. 2. Dong H, et al. 1999. Nat. Med. 5:1365. 3. Freeman G, et al. 2000. J. Exp. Med. 192:1027.
Gene ID: 60533
UniProt: View information about CD274 on UniProt.org
Clone: 10F.9G2
Regulatory Status: RUO
Other Names: B7-H1, PD-L1
Isotype: Rat IgG2b, κ